Cargando…
Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors
SIMPLE SUMMARY: Metastatic prostate cancer (PC) is the second leading cause of cancer deaths in males. The lack of preclinical models and molecular characterization for advanced stage PC is a key barrier in understanding the aggressive subsets androgen receptor (AR) pathway active or AR-null castrat...
Autores principales: | Xue, Caroline, Corey, Eva, Gujral, Taranjit S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997167/ https://www.ncbi.nlm.nih.gov/pubmed/35406510 http://dx.doi.org/10.3390/cancers14071739 |
Ejemplares similares
-
Androgen receptor signaling–mitochondrial DNA–oxidative phosphorylation: A critical triangle in early prostate cancer
por: Sakellakis, Minas, et al.
Publicado: (2022) -
Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer
por: Bader, David A., et al.
Publicado: (2018) -
Anesthetics inhibit phosphorylation of the ribosomal protein S6 in mouse cultured cortical cells and developing brain
por: Friese, Matthew B., et al.
Publicado: (2023) -
KInhibition: A Kinase Inhibitor Selection Portal
por: Bello, Thomas, et al.
Publicado: (2018) -
Non-linear Deep Neural Network for Rapid and Accurate Prediction of Phenotypic Responses to Kinase Inhibitors
por: Vijay, Siddharth, et al.
Publicado: (2020)